BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20413850)

  • 1. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.
    Laumet G; Chouraki V; Grenier-Boley B; Legry V; Heath S; Zelenika D; Fievet N; Hannequin D; Delepine M; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Bertram L; Amouyel P; Lambert JC
    J Alzheimers Dis; 2010; 20(4):1181-8. PubMed ID: 20413850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Alzheimer's disease case-control associations using family-based methods.
    Schjeide BM; McQueen MB; Mullin K; DiVito J; Hogan MF; Parkinson M; Hooli B; Lange C; Blacker D; Tanzi RE; Bertram L
    Neurogenetics; 2009 Feb; 10(1):19-25. PubMed ID: 18830724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the current top candidate genes for AD in a genome-wide association study.
    Feulner TM; Laws SM; Friedrich P; Wagenpfeil S; Wurst SH; Riehle C; Kuhn KA; Krawczak M; Schreiber S; Nikolaus S; Förstl H; Kurz A; Riemenschneider M
    Mol Psychiatry; 2010 Jul; 15(7):756-66. PubMed ID: 19125160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease genetics current status and future perspectives.
    Bertram L
    Int Rev Neurobiol; 2009; 84():167-84. PubMed ID: 19501718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.
    Lambert JC; Grenier-Boley B; Chouraki V; Heath S; Zelenika D; Fievet N; Hannequin D; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Amouyel P
    J Alzheimers Dis; 2010; 20(4):1107-18. PubMed ID: 20413860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S; Väkevä A; Hiltunen M; Soininen H
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association.
    Bettens K; Brouwers N; Van Miegroet H; Gil A; Engelborghs S; De Deyn PP; Vandenberghe R; Van Broeckhoven C; Sleegers K
    J Alzheimers Dis; 2010; 19(4):1169-75. PubMed ID: 20308783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of Alzheimer's disease in the Uppsala Longitudinal Study of Adult Men.
    Giedraitis V; Kilander L; Degerman-Gunnarsson M; Sundelöf J; Axelsson T; Syvänen AC; Lannfelt L; Glaser A
    Dement Geriatr Cogn Disord; 2009; 27(1):59-68. PubMed ID: 19141999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
    Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
    J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population.
    Verpillat P; Bouley S; Campion D; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Antérion C; Agid Y; Brice A; Clerget-Darpoux F
    Eur J Hum Genet; 2001 Jun; 9(6):464-8. PubMed ID: 11436129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell adhesion molecules contribute to Alzheimer's disease: multiple pathway analyses of two genome-wide association studies.
    Liu G; Jiang Y; Wang P; Feng R; Jiang N; Chen X; Song H; Chen Z
    J Neurochem; 2012 Jan; 120(1):190-8. PubMed ID: 22017384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of common and disease specific variants in CLU, CR1, and PICALM.
    Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
    Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients.
    Middle F; Pritchard AL; Handoko H; Haque S; Holder R; Bentham P; Lendon CL
    J Alzheimers Dis; 2010; 20(2):561-7. PubMed ID: 20182055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
    Zubenko GS; Hughes HB; Stiffler JS
    Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.
    Prince JA; Feuk L; Sawyer SL; Gottfries J; Ricksten A; Nägga K; Bogdanovic N; Blennow K; Brookes AJ
    Eur J Hum Genet; 2001 Jun; 9(6):437-44. PubMed ID: 11436125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
    Cellini E; Tedde A; Bagnoli S; Pradella S; Piacentini S; Sorbi S; Nacmias B
    Arch Neurol; 2009 Oct; 66(10):1260-6. PubMed ID: 19822782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the SORL1 gene in Alzheimer's disease and cognitive function.
    Liu F; Ikram MA; Janssens AC; Schuur M; de Koning I; Isaacs A; Struchalin M; Uitterlinden AG; den Dunnen JT; Sleegers K; Bettens K; Van Broeckhoven C; van Swieten J; Hofman A; Oostra BA; Aulchenko YS; Breteler MM; van Duijn CM
    J Alzheimers Dis; 2009; 18(1):51-64. PubMed ID: 19584446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: genetic polymorphisms and rate of decline.
    Schmidt C; Wolff M; von Ahsen N; Zerr I
    Dement Geriatr Cogn Disord; 2012; 33(2-3):84-9. PubMed ID: 22414550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.